Bleeding Outcomes of Ticagrelor Loading in STEMI Thrombolysis with Streptokinase and Tenecteplase: A Single-Centre Retrospective Study in a Malaysian Population
Malaysian Journal of Emergency Medicine · 2025
DOI: 10.64392/gmfy4y63 ↗Kurz gefasst
Fachartikel in der Zeitschrift Malaysian Journal of Emergency Medicine, 2025. Verfasst von Hock Peng Koh und 2 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
Ticagrelor loading in ST-elevation myocardial infarction (STEMI) thrombolysis is not uncommon, particularly in cases initially planned for primary percutaneous coronary intervention but later cancelled and diverted to thrombolytic therapy. However, data onbleeding outcomes with ticagrelor loading, rather than clopidogrel loading, in thrombolytic therapy among Asian STEMI patients are limited. This study aimed to assess bleeding outcomes among STEMI patients who received a loading dose of ticagrelor for STEMI thrombolysis.
Methods
This single-centre retrospective study collected data from STEMI patients who presented between January 2021 and March 2024 and received a 180 mg loading dose of ticagrelor (alongside acetylsalicylic acid and fondaparinux) in the Emergency Department (ED) for thrombolytic therapy. Consecutive patient enrolment was performed. Any bleeding event, classified according to thrombolysis in myocardial infarction (TIMI) bleeding criteria, was the primary endpoint.
Results
A total of 117 patients were included in the final analyses. Their mean age was 57.2±12.4 years, and they were predominantly male (n=105, 89.7%). Most patients had MI with anterior involvement STEMI (n=67, 57.3%) and received tenecteplase as thrombolytic therapy (n=84, 71.8%). The in-hospital mortality rate was 15.4% (n=18). No major or minor bleeding was observed within 24 hours after the administration of the ticagrelor loading agent or thrombolytic agent. Eight (6.8%) minimal bleeding events (7 cases of gum bleeding and 1 case of epistaxis) occurred in the ED; all gum bleeding cases were treated with a tranexamic acid gargle.
Conclusion
This study suggests acceptable short-term bleeding outcomes with ticagrelor loading for STEMI thrombolysis among our Asian population. However, more extensive studies with a control group are needed to confirm these findings further.
Zitieren
APA
Koh, H. P., Nagarajah, J. R., & Lai, S. N. (2025). Bleeding Outcomes of Ticagrelor Loading in STEMI Thrombolysis with Streptokinase and Tenecteplase: A Single-Centre Retrospective Study in a Malaysian Population. Malaysian Journal of Emergency Medicine. https://doi.org/10.64392/gmfy4y63
Vancouver
Koh HP, Nagarajah JR, Lai SN. Bleeding Outcomes of Ticagrelor Loading in STEMI Thrombolysis with Streptokinase and Tenecteplase: A Single-Centre Retrospective Study in a Malaysian Population. Malaysian Journal of Emergency Medicine. 2025. doi:10.64392/gmfy4y63
BibTeX
@article{Koh2025,
author = {Koh, Hock Peng and Nagarajah, Jivanraj R. and Lai, Sin Nan},
title = {Bleeding Outcomes of Ticagrelor Loading in STEMI Thrombolysis with Streptokinase and Tenecteplase: A Single-Centre Retrospective Study in a Malaysian Population},
journal = {Malaysian Journal of Emergency Medicine},
year = {2025},
doi = {10.64392/gmfy4y63}
}
EUVIMED